Clinical Diagnostics Market: By Test, By Product, By End User and Geography

Clinical Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), By Product (Instruments, Reagents, and Data Management Systems), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, and Other End Users) and Region

Clinical Diagnostics Market size was valued at US$ 50.11 billion in 2023, growing at a significant CAGR of 5.02% over 2024-2030. Some of the key factors influencing the market growth include growth in patients with long-term diseases/ disorders like diabetes, cardiovascular diseases, hypertension, etc. where frequent testing is required. Also increase in the geriatric population plays a key role in the market. Expansion and advancements of these diagnostic tests are also thriving the market growth. An increase in health expenditure, rising in awareness about health care, and testing in people are the important factors of the market growth.

However, the high requirement of initial capital amount, stringent regulations by the government, complex operating procedure of equipment, and lack of skilled professionals are somehow restraining the market in some regions.  Clinical diagnostics is the process of identifying a disease by signs, symptoms, a patient's medical history, and a physical examination. They include the production, development, and marketing of test kits, automated test systems, and informatics systems. They aid in disease management to enhance patients' overall health and well-being. They also assist in the classification of patients with various diseases so that focused medication can be given to them. Additionally, they can enhance the effectiveness of medicines, forecast therapeutic efficacy, and protect patients from long-term problems. As a result, clinical diagnostics are widely used in point-of-care testing, diagnostic laboratories, and hospital laboratories all over the world. 

Clinical Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.02%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Clinical Diagnostics Market Dynamics

The development of complex and specialised tests for early illness diagnosis and disease management, as well as rising demand for lab automation, are expected to fuel expansion in the worldwide clinical diagnostics market throughout the forecast period. The growing use of point-of-care diagnostics has ushered in a trend of decentralisation in the healthcare business.

Clinical Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 50.11 billion

Market CAGR

5.02%

By Test Type

  • Lipid Panel
  • Metabolic Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests

By Product

  • Instruments
  • Reagents
  • Data Management Systems

By End User

  • Hospital
  • Diagnostic Laboratory
  • Point-of-Care Testing
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Key Features of the Report

  • The clinical diagnostics market report provides granular level information about the market size, regional market share, historic market, and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup's details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The global clinical diagnostics market size was valued at US$ 50.11 billion in 2023, growing at a CAGR of 5.02% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The key players of the market are Abbott Laboratories, ARUP Laboratories, Bioscientia Healthcare, Bio-Rad Laboratories Inc. Bio-Reference Laboratories, BioMerieux, Charles River, Laboratories, Clarient Inc., Danaher Corporation, Becton Dickinson and Company, Diasorin, Genoptix Medical Laboratory, Genzyme Corporation, Healthscope Limited., Hologic Inc, Labco S.A., Laboratory Corporation of America, Holdings (LabCorp), Ortho Clinical Diagnostics, Qiagen, Quest Diagnostics Inc., Roche Diagnostics, Siemens AG Healthcare Sonic Healthcare Ltd, Thermo Fisher Scientific.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Clinical Diagnostics Market Introduction 
2.1.Global Clinical Diagnostics Market  - Taxonomy
2.2.Global Clinical Diagnostics Market  - Definitions
2.2.1.Test Type
2.2.2.Product
2.2.3.End User
2.2.4.Region
3.Global Clinical Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Clinical Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Clinical Diagnostics Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Lipid Panel
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Metabolic Panel
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Liver Panel
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Renal Panel
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Complete Blood Count
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Electrolyte Testing
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Infectious Disease Testing
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Other Tests
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6.Global Clinical Diagnostics Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Instruments
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Reagents
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Data Management Systems
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Clinical Diagnostics Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Laboratory
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Point-of-Care Testing
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Other End Users
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Clinical Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Lipid Panel
9.1.2.Metabolic Panel
9.1.3.Liver Panel
9.1.4.Renal Panel
9.1.5.Complete Blood Count
9.1.6.Electrolyte Testing
9.1.7.Infectious Disease Testing
9.1.8.Other Tests
9.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Instruments
9.2.2.Reagents
9.2.3.Data Management Systems
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital
9.3.2.Diagnostic Laboratory
9.3.3.Point-of-Care Testing
9.3.4.Other End Users
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Lipid Panel
10.1.2.Metabolic Panel
10.1.3.Liver Panel
10.1.4.Renal Panel
10.1.5.Complete Blood Count
10.1.6.Electrolyte Testing
10.1.7.Infectious Disease Testing
10.1.8.Other Tests
10.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Instruments
10.2.2.Reagents
10.2.3.Data Management Systems
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital
10.3.2.Diagnostic Laboratory
10.3.3.Point-of-Care Testing
10.3.4.Other End Users
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Lipid Panel
11.1.2.Metabolic Panel
11.1.3.Liver Panel
11.1.4.Renal Panel
11.1.5.Complete Blood Count
11.1.6.Electrolyte Testing
11.1.7.Infectious Disease Testing
11.1.8.Other Tests
11.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Instruments
11.2.2.Reagents
11.2.3.Data Management Systems
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital
11.3.2.Diagnostic Laboratory
11.3.3.Point-of-Care Testing
11.3.4.Other End Users
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Lipid Panel
12.1.2.Metabolic Panel
12.1.3.Liver Panel
12.1.4.Renal Panel
12.1.5.Complete Blood Count
12.1.6.Electrolyte Testing
12.1.7.Infectious Disease Testing
12.1.8.Other Tests
12.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Instruments
12.2.2.Reagents
12.2.3.Data Management Systems
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital
12.3.2.Diagnostic Laboratory
12.3.3.Point-of-Care Testing
12.3.4.Other End Users
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Clinical Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Lipid Panel
13.1.2.Metabolic Panel
13.1.3.Liver Panel
13.1.4.Renal Panel
13.1.5.Complete Blood Count
13.1.6.Electrolyte Testing
13.1.7.Infectious Disease Testing
13.1.8.Other Tests
13.2.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Instruments
13.2.2.Reagents
13.2.3.Data Management Systems
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital
13.3.2.Diagnostic Laboratory
13.3.3.Point-of-Care Testing
13.3.4.Other End Users
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.ARUP Laboratories
14.2.3.Bioscientia Healthcare
14.2.4.Bio-Rad Laboratories Inc.
14.2.5.Bio-Reference Laboratories
14.2.6.BioMerieux
14.2.7.Charles River Laboratories
14.2.8.Clarient Inc.
14.2.9.Danaher Corporation
14.2.10.Becton, Dickinson and Company
14.2.11.Diasorin
14.2.12.Genoptix Medical Laboratory
14.2.13.Genzyme Corporation
14.2.14.Healthscope Limited.
14.2.15.Hologic Inc
14.2.16.Labco S.A.
14.2.17.Laboratory Corporation of America Holdings (LabCorp)
14.2.18.Ortho Clinical Diagnostics
14.2.19.Qiagen
14.2.20.Quest Diagnostics Inc.
14.2.21.Roche Diagnostics
14.2.22.Siemens AG Healthcare
14.2.23.Sonic Healthcare Ltd
14.2.24.Thermo Fisher Scientific
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • ARUP Laboratories
  • Bioscientia Healthcare
  • Bio-Rad Laboratories Inc.
  • Bio-Reference Laboratories
  • BioMerieux
  • Charles River Laboratories
  • Clarient Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Diasorin
  • Genoptix Medical Laboratory
  • Genzyme Corporation
  • Healthscope Limited.
  • Hologic Inc
  • Labco S.A.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho Clinical Diagnostics
  • Qiagen
  • Quest Diagnostics Inc.
  • Roche Diagnostics
  • Siemens AG Healthcare
  • Sonic Healthcare Ltd
  • Thermo Fisher Scientific

Related Industry Reports